BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2609704)

  • 1. [Plasma cholecystokinin level in chronic pancreatitis].
    Mössner J; Back T; Regner U; Fischbach W
    Z Gastroenterol; 1989 Aug; 27(8):401-5. PubMed ID: 2609704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meal-related changes in plasma CCK bioactivity in patients with chronic pancreatitis.
    Nakamura T; Tando Y; Yamada N; Imamura K; Ishii M; Terada A; Takebe K; Kaji A; Watanabe T; Suda T; Koide M; Otsuki M
    Acta Gastroenterol Belg; 1998; 61(4):400-6. PubMed ID: 9923089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation.
    Slaff JI; Wolfe MM; Toskes PP
    J Lab Clin Med; 1985 Mar; 105(3):282-5. PubMed ID: 3973464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma cholecystokinin response after ingestion of a test meal in patients with chronic pancreatitis.
    Funakoshi A; Nakano I; Shinozaki H; Ibayashi H; Tateishi K; Hamaoka T
    Am J Gastroenterol; 1985 Dec; 80(12):937-40. PubMed ID: 4073000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cholecystokinin and somatostatin levels in chronic pancreatitis patients.
    al-Eryani S; Duris I; Payer J; Huorka M; Kratochvílová H; Ondrejka P
    Hepatogastroenterology; 2000; 47(33):869-74. PubMed ID: 10919050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of CCK receptor antagonists on plasma CCK bioassay].
    Sun G; Pan GZ; Ma F; Wen SH; Du SF
    Sheng Li Xue Bao; 1992 Dec; 44(6):609-13. PubMed ID: 1302379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
    Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
    Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain.
    Funakoshi A; Nakano I; Shinozaki H; Tateishi K; Hamaoka T; Ibayashi H
    Am J Gastroenterol; 1986 Dec; 81(12):1174-8. PubMed ID: 3538853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
    Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
    Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
    Chowdhury P; Rayford PL
    Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
    Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
    Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma cholecystokinin concentration in patients with chronic pancreatitis measured by bioassay].
    Koide M; Okabayashi Y; Hasegawa H; Tani S; Fujisawa T; Nakamura T; Fujii M; Otsuki M
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2419-24. PubMed ID: 2480463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-stimulated peak lipase concentration in duodenal drainage fluid: a new pancreatic function test.
    Conwell DL; Zuccaro G; Morrow JB; Van Lente F; Obuchowski N; Vargo JJ; Dumot JA; Trolli P; Shay SS
    Am J Gastroenterol; 2002 Jun; 97(6):1392-7. PubMed ID: 12094856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis.
    Cantor P; Petronijevic L; Worning H
    Pancreas; 1986; 1(6):488-93. PubMed ID: 3562443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of neurotensin and CCK in patients with chronic pancreatitis with and without enzyme substitution.
    Nustede R; Köhler H; Fölsch UR; Schafmayer A
    Pancreas; 1991 May; 6(3):260-5. PubMed ID: 1713670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cholecystokinin and pancreatic enzyme secretion in patients with coeliac sprue.
    Koop I; Bozkurt T; Adler G; Schafmayer A; Becker HD; Arnold R
    Z Gastroenterol; 1987 Feb; 25(2):124-9. PubMed ID: 2436388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impairment of humoral regulation of exocrine pancreatic function in chronic pancreatitis].
    Vinokurova LV; Valitova ER; Trubitsyna IE; Shustova SG; Iashina NI; Tkachenko EV
    Ter Arkh; 2007; 79(2):44-8. PubMed ID: 17460968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bombesin on plasma cholecystokinin in normal persons and gastrectomized patients measured by sequence-specific radioimmunoassays.
    Jansen JB; Lamers CB
    Surgery; 1984 Jul; 96(1):55-60. PubMed ID: 6740496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans.
    Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB
    Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.